Pivotal regulatory milestone in high stakes applications Cellvizio first-to-market in key neurosurgery field Provides unique response to unmet needs...
Results from new clinical study that enrolled 172 patients at 8 non-academic centers in the United-States was presented at 2018 World Congress of...
Mauna Kea Technologies has appointed Christophe Lamboeuf to the position of Chief Financial Officer. Christophe Lamboeuf succeeds Olivier...
According to the publication in Nature Group’s Scientific Reports, this discovery may have significance in cancer metastasis and other...
New Health Technology Assessment (nHTA) Committee recognizes confocal laser endomicroscopy as “safe and effective technology in application...
Mauna Kea Technologies announced the appointment of Molly O’Neill to the Company’s Board of Directors, effective immediately. She...
Pivotal regulatory milestone positioning Cellvizio as unique real-time in vivo visualization system Cellvizio platform complementary to a wide range...
Please download the official press release for full details
Croatian Health Insurance Fund Now Provides Reimbursement for Cellvizio® advanced endomicroscopy technology for patients affected by...
New CONTACT Study Outcomes Presented today in Late-Breaking Session at United European Gastroenterology Week (UEGW) 2017 Mauna Kea Technologies...
Mauna Kea Technologies announced the appointment of Olivier Regnard to the position of Deputy Chief Executive Officer and Chief Financial...
Study shows a 23% reduction in surgical interventions resulting in 14% reduction in clinical costs Mauna Kea Technologies today announced the...
